REG - AIM - AIM Notice - 21/04/2026

Globalworth Real Estate InvestmentsAnnouncement

Today 09:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260421:nRSU1847Ba&default-theme=true

RNS Number : 1847B  AIM  21 April 2026

NOTICE

 

21/04/2026 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 Galantas Gold Corporation
 40,500,000  COMMON SHARES OF NO PAR VALUE, FULLY PAID  (BM962Z1)(CA36315W3012)

 

 Globalworth Real Estate Investments Limited
 10,028,162  ORDINARY SHARES OF NO PAR VALUE EACH; FULLY PAID  (B979FD0)(GG00B979FD04)

 

 QUANTUM BLOCKCHAIN TECHNOLOGIES PLC
 142,857,142  ORDINARY SHARES OF 0.25P EACH, FULLY PAID  (B50P5B5)(GB00B50P5B53)

 

 Spectra Systems Corporation
 16,199  COMMON SHARES OF USD0.01 EACH FULLY PAID (DI/REGULATION S)  (B5LW3S8)(USU8457D1091)

 

 Trellus Health Plc
 48,718,698  ORDINARY SHARES OF GBP0.0006 EACH FULLY PAID  (BNNFM40)(GB00BNNFM402)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBUGDSRGDDGLG



            Copyright 2019 Regulatory News Service, all rights reserved